We hypothesized that glycosylation changes in proteins that are solely or predominantly expressed in the brain, such as neuronal cell adhesion molecules or prostaglandin-H2 D-isomerase, can give novel insights into brain-specific disease mechanism and can lead to the development of more accurate and sensitive glycan-based biomarkers in neurological diseases. The gene discussed is PTGDS; the disease is nervous system disorder.